In the news
For 2021, cell, gene therapies make Prime’s “Drugs to Watch” list
April 16, 2021AJMC
Related news
In the news
March 29, 2023
Adeno-Associated Virus Gene Therapies in the Pipeline, Barriers to Existing Drugs and Solutions | AMCP 2023
Managed Healthcare Executive
In the news
March 29, 2023
Magellan Team Discusses ‘Mortgage-like’ Payments For Ultra-Expensive Gene Therapies | AMCP 2023
Managed Healthcare Executive
In the news
March 27, 2023
Getting Ophthalmic Biosimilars to Market Continues to Prove Difficult
American Journal of Managed Care